Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

285 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Quantitative analysis of T helper 1, T helper 2, and inflammatory cytokine expression in patients after allogeneic bone marrow transplantation: relationship with the occurrence of acute graft-versus-host disease.
Carayol G, Bourhis JH, Guillard M, Bosq J, Pailler C, Castagna L, Vernant JP, Pico JL, Hayat M, Chouaib S, Caignard A. Carayol G, et al. Among authors: vernant jp. Transplantation. 1997 May 15;63(9):1307-13. doi: 10.1097/00007890-199705150-00019. Transplantation. 1997. PMID: 9158026
Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM).
Socié G, Cahn JY, Carmelo J, Vernant JP, Jouet JP, Ifrah N, Milpied N, Michallet M, Lioure B, Pico JL, Witz F, Molina L, Fischer A, Bardou VJ, Gluckman E, Reiffers J. Socié G, et al. Among authors: vernant jp. Br J Haematol. 1997 Jun;97(4):865-70. doi: 10.1046/j.1365-2141.1997.1262940.x. Br J Haematol. 1997. PMID: 9217190 Free article.
Cost effectiveness of day 5 G-CSF (Lenograstim) administration after PBSC transplantation: results of a SFGM-TC randomised trial.
Valteau-Couanet D, Faucher C, Aupérin A, Michon J, Milpied N, Boiron JM, Bourhis JH, Gisselbrecht C, Vernant JP, Pinna A, Bendahmane B, Delabarre F, Benhamou E. Valteau-Couanet D, et al. Among authors: vernant jp. Bone Marrow Transplant. 2005 Sep;36(6):547-52. doi: 10.1038/sj.bmt.1705097. Bone Marrow Transplant. 2005. PMID: 16007101 Clinical Trial.
Extensive chronic GVHD is associated with donor blood CD34+ cell count after G-CSF mobilization in non-myeloablative allogeneic PBSC transplantation.
Dhédin N, Prébet T, De Latour RP, Katsahian S, Kuentz M, Piard N, Réa D, Norol F, Jouet JP, Ribeil JA, Tabrizi R, Rio B, Lioure B, Tiberghien P, Bourhis JH, Sirvent A, Bordigoni P, Blaise D, Michallet M, Vernant JP. Dhédin N, et al. Among authors: vernant jp. Bone Marrow Transplant. 2012 Dec;47(12):1564-8. doi: 10.1038/bmt.2012.75. Epub 2012 May 21. Bone Marrow Transplant. 2012. PMID: 22609881
Consolidation treatment of adult acute lymphoblastic leukemia: a prospective, randomized trial comparing allogeneic versus autologous bone marrow transplantation and testing the impact of recombinant interleukin-2 after autologous bone marrow transplantation. BGMT Group.
Attal M, Blaise D, Marit G, Payen C, Michallet M, Vernant JP, Sauvage C, Troussard X, Nedellec G, Pico J, et al. Attal M, et al. Among authors: vernant jp. Blood. 1995 Aug 15;86(4):1619-28. Blood. 1995. PMID: 7632972 Free article. Clinical Trial.
The use of a sequential high dose recombinant interleukin 2 regimen after autologous bone marrow transplantation does not improve the disease free survival of patients with acute leukemia transplanted in first complete remission.
Blaise D, Attal M, Pico JL, Reiffers J, Stoppa AM, Bellanger C, Molina L, Nedellec G, Vernant JP, Legros M, Gabus R, Huguet F, Brandely M, Hercend T, Olive D, Maraninchi D. Blaise D, et al. Among authors: vernant jp. Leuk Lymphoma. 1997 May;25(5-6):469-78. doi: 10.3109/10428199709039034. Leuk Lymphoma. 1997. PMID: 9250817 Clinical Trial.
Predictive value of host-specific donor helper T-cell precursor frequency for acute graft-versus-host disease and relapse in HLA-identical siblings receiving allogeneic bone marrow transplantation for hematological malignancies.
Lachance S, Le Gouvello S, Roudot F, Kuentz M, Bernaudin F, Beaujean F, Bierling P, Cordonnier C, Farcet JP, Vernant JP. Lachance S, et al. Among authors: vernant jp. Transplantation. 1997 Oct 27;64(8):1147-52. doi: 10.1097/00007890-199710270-00012. Transplantation. 1997. PMID: 9355832
285 results